|20th October 2020||Jay T Flatley||3,000||Open or private sale||$320.95||$962,850.00|
|20th October 2020||Jay T Flatley||1,000||Open or private sale||$324.01||$324,010.00|
|12th October 2020||Susan H Tousi||200||Open or private sale||$350.00||$70,000.00|
|7th October 2020||Jay T Flatley||1,000||Open or private sale||$324.01||$324,010.00|
|7th October 2020||Susan H Tousi||100||Open or private sale||$325.00||$32,500.00|
|6th October 2020||Jay T Flatley||3,000||Open or private sale||$317.79||$953,370.00|
|5th October 2020||Kathryne Gambrell Reeves||1,187||Grant/award etc.||$0.00|
|5th October 2020||Joydeep Goswami||115||Payment by withholding||$316.17||$36,359.55|
|1st October 2020||Francis A De Souza||559||Open or private sale||$307.78||$172,049.02|
|1st October 2020||Francis A De Souza||785||Open or private sale||$306.99||$240,987.15|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of -7/10.
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems. The firm's products include microarray scanners, sequencing reagents, and onsite training selector. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting.